Assessment of the Role of IQ in Associations Between Population Density and Deprivation and Nonaffective Psychosis.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
pubmed:
12
3
2020
medline:
13
2
2021
entrez:
12
3
2020
Statut:
ppublish
Résumé
Being born or raised in more densely populated or deprived areas is associated with increased risk of nonaffective psychosis in adulthood, but few studies to date have examined the role of general cognitive ability in these associations. To investigate whether lower IQ contributed to the association between population density or deprivation and nonaffective psychosis (mediation) and whether these associations were stronger in people with lower IQ (effect modification). This prospective cohort study evaluated a population-based sample of men born in Sweden from January 1, 1982, to December 31, 1988, and conscripted into military service at 18 years of age. Data were collected from January 1, 1982, to December 31, 2016, and analyzed from May 1 to December 31, 2018. Continuous measures of small area-level population density (persons per square kilometer) and socioeconomic deprivation at birth. Deprivation was based on area-level social, criminal, and unemployment data. IQ was assessed during conscription at 18 years of age (mean [SD] IQ, 100 [15]). First diagnosis of International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, nonaffective psychosis from 18 years of age until December 31, 2016, recorded in the National Patient Register. The study sample included a total of 227 429 men who were classified as at risk of psychosis from 18 years of age until the end of follow-up. Of these, 1596 men (0.7%) were diagnosed with nonaffective psychosis. After adjustments for confounders, odds of nonaffective psychosis increased per 1-SD increase in population density (odds ratio [OR], 1.07; 95% CI, 1.04-1.14) and deprivation (OR, 1.09; 95% CI, 1.02-1.13) at birth. IQ was negatively associated with deprivation after adjustments (effect estimate per 1-SD increase in deprivation: -0.70 points; 95% CI, -0.78 to -0.62 points) but not with population density. In mediation analyses, based on the potential outcome framework, 23% (95% CI, 17%-49%) of the total effect of deprivation on nonaffective psychosis was mediated by IQ. IQ did not modify associations between deprivation or population density and nonaffective psychosis. These findings suggest that being born in more deprived neighborhoods may partly increase risk of nonaffective psychosis through subsequent effects on cognitive development, consistent with the wider literature on neurodevelopmental delays associated with psychotic disorder. Identifying factors in deprived environments that give rise to this process could inform public health strategies to prevent nonaffective psychosis.
Identifiants
pubmed: 32159742
pii: 2762528
doi: 10.1001/jamapsychiatry.2020.0103
pmc: PMC7066518
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
729-736Subventions
Organisme : Medical Research Council
ID : G0701503
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201486/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 101272/Z/13/Z
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Références
Int J Epidemiol. 2018 Aug 1;47(4):1117-1119
pubmed: 30184137
World Psychiatry. 2013 Oct;12(3):187-97
pubmed: 24096775
Schizophr Bull. 2012 Nov;38(6):1118-23
pubmed: 23015685
Schizophr Bull. 2017 Sep 1;43(5):1056-1063
pubmed: 28338769
J Int Neuropsychol Soc. 2002 Mar;8(3):448-60
pubmed: 11939702
Acta Psychiatr Scand. 2010 May;121(5):389-92
pubmed: 19878139
Prog Neurobiol. 2011 Jan;93(1):23-58
pubmed: 20955757
JAMA Psychiatry. 2017 Jul 1;74(7):703-711
pubmed: 28538982
Arch Gen Psychiatry. 2004 Apr;61(4):354-60
pubmed: 15066893
Psychol Aging. 2011 Mar;26(1):232-40
pubmed: 20973608
JAMA Psychiatry. 2018 Apr 1;75(4):356-362
pubmed: 29450471
Schizophr Bull. 2020 Apr 10;46(3):581-591
pubmed: 31167032
Am J Epidemiol. 2006 Jun 1;163(11):971-8
pubmed: 16675535
Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):425-30
pubmed: 22203952
Psychol Methods. 2010 Dec;15(4):309-34
pubmed: 20954780
Schizophr Bull. 2014 Jan;40(1):169-80
pubmed: 23236081
Psychol Med. 2018 Jan;48(2):305-314
pubmed: 28659227
Psychol Med. 1997 Nov;27(6):1311-23
pubmed: 9403903
Behav Res Ther. 1994 Mar;32(3):331-41
pubmed: 8192633
Schizophr Bull. 2015 Mar;41(2):494-502
pubmed: 25053652
J Epidemiol Community Health. 2004 Apr;58(4):265-71
pubmed: 15026432
N Engl J Med. 1999 Feb 25;340(8):603-8
pubmed: 10029644
Int J Epidemiol. 2002 Apr;31(2):422-9
pubmed: 11980807
JAMA Psychiatry. 2018 Sep 1;75(9):901-910
pubmed: 29936532
JAMA Psychiatry. 2018 Nov 1;75(11):1128-1136
pubmed: 30140915
JAMA Psychiatry. 2018 Jul 1;75(7):678-686
pubmed: 29799917
Schizophr Bull. 2013 Nov;39(6):1328-36
pubmed: 23236077
Intelligence. 2015 Jan-Feb;48:30-36
pubmed: 26640306
JAMA Psychiatry. 2018 Jan 1;75(1):36-46
pubmed: 29214289
Schizophr Res. 2011 Nov;132(2-3):220-7
pubmed: 21764562
Psychol Sci. 2018 Aug;29(8):1358-1369
pubmed: 29911926
Lancet. 2014 May 10;383(9929):1677-1687
pubmed: 24315522
Psychol Bull. 2014 Jul;140(4):949-79
pubmed: 24611582
Lancet. 1994 Nov 19;344(8934):1398-402
pubmed: 7968076
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Arch Gen Psychiatry. 2010 Sep;67(9):914-22
pubmed: 20819985
Schizophr Res. 2010 Jan;116(1):75-89
pubmed: 19897342
Br J Psychiatry. 2004 Apr;184:293-8
pubmed: 15056572
Neuropsychopharmacology. 2016 Feb;41(3):666-74
pubmed: 26346639
JAMA Psychiatry. 2018 Dec 1;75(12):1211-1212
pubmed: 30304485
Nat Rev Genet. 2018 Mar;19(3):148-159
pubmed: 29335645
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Transl Psychiatry. 2016 May 03;6:e796
pubmed: 27138795